The former ACIP members are “deeply concerned that these destabilizing decisions may roll back the achievements of US immunization policy.” ...

The initiative, referred to as the Commissioner’s National Priority Voucher program, allows drug developers to participate in a novel FDA priority program. The program significantly shortens the FDA ...

In this case, the clinician’s misdiagnosis was compounded by a failure to properly communicate follow-up instructions, a failure to take good notes, and an attempt to place the blame on the patient ...

Vaccine makers will have to run large new trials before updated shots can be approved for everyone who is not at a higher-than-average risk.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Pediatricians should provide teens with their contraceptive of choice on the same day as counseling, in the absence of medical contraindications.

We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.

Between 2012 and 2022, incidence rates of breast cancer increased by 1% per year in women older than 50 years and by 1.4% in women younger than 50 years.

With CASPA open for the 2025-2026 application cycle, aspiring PA students look towards pre-PA prep courses to help them get into their first-choice school. Are such programs needed?

Adjuvant cemiplimab could be a new standard of care for patients with cutaneous squamous cell carcinoma at high risk of recurrence, according to Danny Rischin, MD.

Amneal Pharmaceuticals is recalling 3 lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg due to Aspergillus contamination. Sulfamethoxazole/Trimethoprim is indicated ...